Preoperative Imaging and Operative Procedures
Procedure | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
Conventional imaging | |||||
CT | FN | NA | NA | NA | NA |
ASVS | FN | FN | NA | NA | NA |
Endoscopic ultrasound | FN | FN | FN | NA | NC |
MR imaging | FN | FN | FN | − | TP |
111In-DOTA-exendin-4 SPECT/CT | |||||
Detection of tumor 4 h after injection | FN | TP | TP | + | FN |
Tumor-to-background ratio at 4 h | NA | 1.04 | 3.87 | 1.96 | NA |
Detection of tumor 72 h after injection | FP | TP | TP | + | FP |
Tumor-to-background ratio at 72 h | NA | 1.12 | 3.93 | 2.04 | NA |
68Ga-DOTA-exendin-4 PET/CT | |||||
Detection of tumor | TP | TP | TP | + | TP |
Tumor-to-background ratio | 2.00 | 3.79 | 6.87 | 5.95 | 32.42 |
SUVmax of tumor | 5.5 | 10.8 | 49.1 | 25 | 30.8 |
Surgery and histology | |||||
Surgical procedure | Enucleation | Pancreas tail resection | Pancreas tail resection | Not operated | Enucleation |
Localization | Body/tail transition | Tail | Tail | NA | Tail |
Dimension (mm) | 8 | 10 | 10 | NA | 18 |
Histopathology | Insulinoma | Insulinoma | Insulinoma | NA | Insulinoma |
ASVS = selective arterial calcium stimulation and hepatic venous sampling; SUVmax = maximal standardized uptake value; NA = not applicable; NC = not conclusive; FN = false-negative; FP = false-positive; TP = true-positive; − = negative result; + = positive result.